Sedigheh Moghassemi1, Saeideh Ziaei, Zainab Haidari. 1. Department of Midwifery, Faculty of Nursing & Midwifery, Golestan University of Medical Sciences, Gorgan, Iran. moghasemi.s@gmail.com
Abstract
INTRODUCTION: Female sexual dysfunction is a current and multifactorial status that greatly affects quality of life. Menopause, aging, and probably hormonal instability are some of these drastic factors. AIM: Determine the prevalence of sexual dysfunction in Iranian postmenopausal women and the relationship to serum status of sex hormones and sex hormone binding globulin (SHBG). METHODS: A total of 149 healthy postmenopausal women aged 43-64, nonhormone therapy user, with intact uterus and ovaries, enrolled in the cross-sectional study. MAIN OUTCOME MEASURES: Female sexual function was evaluated by utilizing the Female Sexual Function Index. Hormonal serum concentration was measured by enzyme-linked Immunosorbent Assay (ELISA). Also, free testosterone and free estradiol indexes were calculated. The analysis was performed by using SPSS 16. RESULTS: Mean age of sample was 52.19 ± 3.76 with 47.48 ± 36.5 month amenorrhea. In the study, 69.8% of women showed sexual dysfunction in Desire and 61.7% in Arousal, these two being the most affected domains. Lubrication (49.7%), Pain Domain (45.0%), Orgasm (40.3%), and Satisfaction (36.9%) were in later degree among six assessed domains. There was no difference between the two groups-with and without dysfunction-in hormone level and SHBG. CONCLUSION: In Iranian postmenopausal women, Desire and Arousal are the most prevalent menopausal sexual dysfunctions, and Female Sexual Dysfunction is much more than just a hormonal problem.
INTRODUCTION: Female sexual dysfunction is a current and multifactorial status that greatly affects quality of life. Menopause, aging, and probably hormonal instability are some of these drastic factors. AIM: Determine the prevalence of sexual dysfunction in Iranian postmenopausal women and the relationship to serum status of sex hormones and sex hormone binding globulin (SHBG). METHODS: A total of 149 healthy postmenopausal women aged 43-64, nonhormone therapy user, with intact uterus and ovaries, enrolled in the cross-sectional study. MAIN OUTCOME MEASURES: Female sexual function was evaluated by utilizing the Female Sexual Function Index. Hormonal serum concentration was measured by enzyme-linked Immunosorbent Assay (ELISA). Also, free testosterone and free estradiol indexes were calculated. The analysis was performed by using SPSS 16. RESULTS: Mean age of sample was 52.19 ± 3.76 with 47.48 ± 36.5 month amenorrhea. In the study, 69.8% of women showed sexual dysfunction in Desire and 61.7% in Arousal, these two being the most affected domains. Lubrication (49.7%), Pain Domain (45.0%), Orgasm (40.3%), and Satisfaction (36.9%) were in later degree among six assessed domains. There was no difference between the two groups-with and without dysfunction-in hormone level and SHBG. CONCLUSION: In Iranian postmenopausal women, Desire and Arousal are the most prevalent menopausal sexual dysfunctions, and Female Sexual Dysfunction is much more than just a hormonal problem.
Authors: Mohammad Arash Ramezani; Khodabakhsh Ahmadi; Afagh Ghaemmaghami; Esfandiar Azad Marzabadi; Faezeh Pardakhti Journal: Int J Prev Med Date: 2015-05-20